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ABSTRACT
Objective The objective of this study was to determine
outcomes in pregnant women with pre-existing coronary
artery disease (CAD) or following an acute coronary
syndrome (ACS) including myocardial infarction (MI).
Background The physiological changes of pregnancy
can contribute to myocardial ischaemia. The pregnancy
risk for women with pre-established CAD or a history of
ACS/MI is not well studied.
Methods This was a retrospective multicentre study.
Adverse maternal cardiac, obstetric and fetal/neonatal
events were examined. The primary outcome was a
composite endpoint of cardiac arrest, ACS/MI, ventricular
arrhythmia or congestive heart failure. The prevalence of
new or progressive angina during pregnancy was also
examined.
Results Fifty pregnancies in 43 women (mean age 35
±5 years) were included. Coronary atherosclerosis (40%)
and coronary thrombus (36%) were the most common
underlying diagnoses. The primary outcome occurred in
10% (5/50) of pregnancies and included one maternal
death secondary to cardiac arrest. Other events included
ACS/MI (3/50) and heart failure (1/50). New or
progressive angina occurred in 18% of pregnancies.
Ischaemic complications of any type (new or progressive
angina, ACS/MI, ventricular arrhythmia, cardiac arrest)
occurred more commonly in women with coronary
atherosclerosis compared with those without (50% vs
10%, p=0.003). A high rate of adverse obstetric (16%)
and fetal/neonatal (30%) events was observed.
Conclusions Pregnant women with pre-existing CAD
or ACS/MI before pregnancy are at increased risk of
adverse events during pregnancy. Those with coronary
atherosclerosis are at highest risk of adverse maternal
cardiac events due to myocardial ischaemia during
pregnancy.
Current trends have led to an older age at the time
of childbirth and increases in the prevalence of
maternal diabetes, obesity and hypertension. These
factors have contributed to a rising number of
women of childbearing age with pre-existing coronary disease.1–3 Ischaemic cardiac events, such as
acute myocardial infarction (MI) have been associated with high maternal and fetal mortality.4–6
While early case reports on pregnancy risk in
women with pre-existing coronary artery disease
(CAD) reported high maternal mortality,7 subsequent case series reported improved maternal

outcomes.8 9 While many women with pre-existing
CAD or a history of acute coronary syndrome
(ACS) will consider pregnancy, the pregnancy risk
for these women is not deﬁned. The objective of
this study was to determine maternal and fetal/neonatal outcomes in a large contemporary group of
pregnant women with a history of CAD or ACS/MI
prior to pregnancy.

METHODS
Study population
This was a multicentre review of pregnancies in
women seen between 1995 and 2012 at one of the
participating centres (University of Toronto,
Toronto, Canada; University of British Columbia,
Vancouver,
Canada;
Erasmus
University,
Rotterdam, The Netherlands; University Medical
Centre, Groningen, The Netherlands; Academic
Medical Center, Amsterdam, The Netherlands; and
University Medical Center Utrecht, Utrecht, the
Netherlands). This study was approved by the institutional review boards of the participating centres.
Cases were identiﬁed by systematic review of
each institution’s clinical database at each of the
study centres. Inclusion criteria encompassed
women referred with a history of CAD or an ACS,
including MI, preceding pregnancy. ACS was
deﬁned as chest pain, electrocardiographic changes
and abnormal biomarkers not meeting criteria for
MI. MI was deﬁned as elevated cardiac biomarkers
(CK-MB, troponin) with at least one value above
the 99th percentile and one of the following: symptoms of ischaemia, electrocardiographic changes,
imaging evidence of new regional wall-motion
abnormality or loss of viable myocardium, and/or
identiﬁcation of intracoronary thrombus by angiography.10 Unstable angina and coronary spasm were
clinical diagnoses made by the treating physician at
the time of the previous clinical encounter. Women
with ﬁrst presentation of an ACS (including coronary dissection) during a pregnancy were not
included. Women with Kawasaki disease or anomalous coronary arteries without history of ischaemic
events were not included.

Baseline data
Demographic and clinical data were obtained from
chart review and included maternal and gestational
age, parity, earlier interventions, comorbidities (ie,
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Outcomes
The primary maternal cardiac outcomes of interest were cardiac
arrest or cardiac death, sustained or symptomatic ventricular
tachycardia, ACS, MI and pulmonary oedema. In one woman, a
planned elective coronary artery bypass operation was delayed
because of an unexpected pregnancy. The elective bypass took
place postpartum, but was not considered an endpoint. Other
outcomes of interest included new/progressive angina, thromboembolism and atrial arrhythmia requiring treatment. Cardiac
adverse events were further classiﬁed as ischaemic (unstable
angina, MI, ventricular tachyarrhythmia or cardiac arrest) or
non-ischaemic.
Adverse fetal and/or neonatal events included premature birth
(<37 weeks gestation), low birth weight (<2500 g), intrauterine
growth retardation (fetal weight <10th percentile for gestational age), respiratory distress syndrome, intraventricular haemorrhage, spontaneous abortion (<24 weeks) and fetal or
neonatal death.
Adverse obstetric events included pre-eclampsia (diagnosed by
the treating physician) and postpartum haemorrhage (blood loss
>500 mL after vaginal delivery or >1000 mL after caesarean
section).12

Statistics
All data were analysed using SPSS V.16.0 (SPSS, Chicago,
Illinois, USA). Normally distributed continuous variables were
represented as a mean±SD, and categorical variables were
represented as a frequency. The differences between groups
were determined using Student t test or χ2 test; p<0.05 (twosided) was considered to be signiﬁcant.

RESULTS
During the study period, 50 pregnancies were identiﬁed in 43
women with pre-existing CAD or a history of ACS/MI prior to
pregnancy. Baseline characteristics are summarised in table 1.
The majority of women (74%) were multiparous, and the mean
study age was 34±5 years. Established risk factors for coronary
disease were identiﬁed in 80% of women, the most common
being a history of cigarette smoking, present in almost 60%.
The most common diagnoses were atherosclerosis (n=20)
and intracoronary thrombus (n=18). Disorders of hypercoaguability were documented in seven women: Factor V Leiden
mutation (n=3), antiphospholipid syndrome (n=3) and protein
S deﬁciency (n=1). Less common ﬁndings included congenital
ﬁbroelastosis of the left main (n=1) and coronary spasm (n=5).
Cardiac catheterisation had been performed prior to pregnancy
in the majority of cases (n=39, 78%). Coronary atherosclerosis
was diagnosed in 12 women at the time of cardiac catheterisation; these women were older (36±5 years), more likely to be
multiparous ( p=0.01) and to have multivessel disease
( p<0.0001) versus women without atherosclerosis. Women
diagnosed with intracoronary thrombus were younger and were
more likely to be anticoagulated ( p<0.0001). Eleven women
did not undergo cardiac catheterisation after presenting with
ACS. Coronary spasm was diagnosed by the treating physician
as the aetiology of ACS in ﬁve women on the basis of their clinical presentation and investigation results. Aetiology was not
526

Table 1

Baseline characteristics
n (%)

Demographic factors
Women
Pregnancies
Mean age at delivery (years)
Age range (years)
Multiparous
Cardiac diagnosis
Atherosclerosis
Coronary thrombus or embolism
Coronary spasm
Acute coronary syndrome*
Pre-existing coronary risk factors
≥1 risk factor
Smoking
Family history
Hypertension
Dyslipidaemia
Obesity
Diabetes
Thrombophilia†
Cardiac medications at first antenatal visit‡ n=44
Any medication
Aspirin/clopidogrel
β-blocker
Heparin
Warfarin
ACE inhibitor
NYHA functional class at first antenatal visit
I
II–IV
LV systolic function§ n=45
Normal
Mildly reduced
Moderately reduced

43
50
35±5
27–47
37 (74)
20
18
5
6
41 (82)
11 (22)
22 (44)
18 (36)
10 (20)
5 (10)
4 (8)
7 (14)
47 (94)
28
19
8
6
8
42
8
27 (54)
13 (26)
5 (10)

Note: Coronary anatomy findings are mutually exclusive.
*Acute coronary syndrome documented but aetiology not specified.
†Thrombophilia (Factor V Leiden (n=3), antiphospholipid syndrome (n=3), protein S
deficiency (n=1)) confirmed with genetic/lab testing.
‡Medications not documented in six pregnancies.
§LV function assessed by transthoracic echocardiogram at first antenatal visit.
NYHA, New York Heart Association.

documented in six women who met criteria for a history of
ACS prior to pregnancy, but did not undergo cardiac
catheterisation.
Previous cardiac interventions were documented in 54% (27/
50) and included balloon angioplasty (n=5), coronary stent
implantation (n=13), thrombolysis (n=6) and coronary artery
bypass graft (CABG) surgery (n=3). Aspirin was the most
common cardiac medication (n=27, 54%), followed by anticoagulants (n=12, 24%), β-blockers (n=38, 19%) and statins
(n=4, 8%); the latter was stopped during pregnancy. ACE inhibitors had been used by 20% (10/50); these were discontinued
prior to pregnancy in six women, and in the ﬁrst trimester at
the time of their ﬁrst obstetric visit/cardiac review in the remaining four women.

Maternal cardiac outcomes
The primary outcome was observed in 10% (n=5) of pregnancies (tables 2 and 3, ﬁgure 1). There was one sudden death,
8 weeks postpartum, presumed secondary to ventricular
Burchill LJ, et al. Heart 2015;101:525–529. doi:10.1136/heartjnl-2014-306676
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smoking history, diabetes, hypertension, inherited thrombophilia), New York Heart Association (NYHA) functional class, and
medications. Assessment of LV systolic function was based on
clinical reports and classiﬁed as: normal function (LVEF≥55%),
mild (45%–54%), moderate (30%–44%) or severe (<30%) systolic dysfunction.11

Special populations
Table 2 Adverse maternal cardiac events during pregnancy

Total

Secondary cardiovascular endpoint

Any primary event

Cardiac arrest/ventricular
arrhythmia

ACS/MI

Heart failure

Any secondary event

Angina

Stroke/PE

Atrial arrhythmia*

5 (10)

1

3

1

12 (24)

9

2

1

Angina defined as clinical diagnosis by the treating physician resulting in admission or up-titration of antianginal medications.
*Supraventricular tachycardia at 39 weeks gestation.
ACS, acute coronary syndrome; MI, myocardial infarction; PE, pulmonary embolus.

arrhythmia in a woman with a history of MI and moderate LV
systolic dysfunction. Two women with atherosclerotic coronary
disease sustained MI during the postpartum period (at 4 and
8 weeks postpartum). Cardiac catheterisation revealed signiﬁcant
CAD leading to percutaneous coronary intervention in both
patients. A 42-year-old woman with a history of coronary
bypass graft surgery and normal LVEF presented with acute pulmonary oedema at 33 weeks gestation. Pulmonary oedema was
attributed to a combination of factors including possible subclinical LV systolic dysfunction, demand ischaemia, and increased
ventricular ﬁlling pressures. The patient responded well to diuresis and short-term non-invasive positive pressure ventilation for
the treatment of respiratory distress. Primary maternal cardiac
events were more common in women with CAD due to coronary atherosclerosis (ﬁgure 1).
The primary adverse outcomes was not associated with maternal age ( p=0.59), past/active smoking history ( p=0.91), diabetes ( p=0.30), revascularisation prior to pregnancy ( p=0.71),
atherosclerosis/CABG ( p=0.64), multivessel disease ( p=0.38),
thrombophilia ( p=0.34), reduced LVEF ( p=0.39), aspirin use
( p=0.78) or baseline anticoagulation ( p=0.83).

Table 3 Timing of adverse maternal cardiac events
Maternal cardiac
diagnosis

Maternal age
(years)

Cardiac
event

Gestation
(weeks)

8 weeks
postpartum
33 weeks
34 weeks
4 weeks
postpartum
8 weeks
postpartum

Primary cardiac events
Presumed coronary
artery spasm and MI
Coronary atherosclerosis
Coronary thrombus
Coronary atherosclerosis

27

Sudden death

42
32
33

CHF
ACS
MI

Coronary atherosclerosis

32

MI

40
34
41
33
27
28
30
36
41
28
32

CVA
Angina
Angina
Angina
Angina
Angina
Angina
Angina
Angina
SVT
Iliac artery
dissection
Angina

Other cardiac events
Coronary thrombus
Coronary atherosclerosis
Coronary atherosclerosis
Coronary thrombus
Coronary fibroelastosis
Coronary atherosclerosis
Coronary atherosclerosis
Coronary atherosclerosis
Coronary atherosclerosis
Coronary thrombus
Ehlers–Danlos
Syndrome
Coronary atherosclerosis

34

5 weeks
12 weeks
20 weeks
21 weeks
24 weeks
30 weeks
32 weeks
33 weeks
36 weeks
39 weeks
1 week
postpartum
4 weeks
postpartum

ACS, acute coronary syndrome; CHF, congestive heart failure; CVA, cerebrovascular
accident; MI, myocardial infarction; SVT, supraventricular tachycardia.
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Ischaemic cardiac events (new or progressive angina, ACS/MI,
ventricular arrhythmia, cardiac arrest) complicated 26% of the
pregnancies (tables 2 and 3). Treatment of angina, which complicated nine pregnancies, included clinical review alone (n=3),
new antianginal therapy (n=2) and hospital admission with
serial cardiac biomarkers for exclusion of MI (n=1). One
woman had a normal stress echocardiogram at 38 weeks gestation. Two women underwent coronary angiography, one at
38 weeks gestation and the other 4 weeks postpartum. All were
treated medically without angina recurrence, premature onset of
labour, or fetal loss.
Women with pre-existing coronary atherosclerosis and/or
CABG were at highest risk of ischaemic events (48% vs 10%,
p=0.003). Other complications included supraventricular tachycardia in one woman and left frontal lobe embolic stroke in
another; both women had a history of coronary thrombus (table 3).
One woman with Ehlers–Danlos syndrome type IV (vascular
type) developed bilateral dissection of the external iliac arteries
1 week postpartum.

Obstetric outcomes
Sixty-two percent of the deliveries were vaginal. Adverse obstetric outcomes occurred in 16% (n=8) of the pregnancies (table 4
and ﬁgure 1): pre-eclampsia in four women and postpartum
haemorrhage in four women. Three of the four women diagnosed with pre-eclampsia had proven coronary atherosclerosis
and two of four women in whom postpartum haemorrhage
occurred were receiving anticoagulants for coronary thrombus.
There were no deaths due to obstetric complications.

Fetal and neonatal outcomes
The median gestational age at live delivery was 38 weeks and
median birth weight was 3050 g. Fifteen of 50 (30%) pregnancies were complicated by an adverse fetal/neonatal event
(table 4 and ﬁgure 1). Three pregnancies ended in spontaneous
abortion (<20 weeks gestation). One pregnancy ended in fetal

Figure 1 Frequency of maternal cardiac and fetal/neonatal events
during pregnancy in women pre-existing coronary artery disease or
following an acute coronary syndrome.
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Table 4 Adverse obstetric, fetal and neonatal outcomes

Adverse obstetric outcomes
Total events
Pre-eclampsia
Postpartum haemorrhage
Non-cardiac death
Adverse fetal/neonatal outcomes*
Total events
Preterm delivery (<37 weeks)
Low birth weight
Intrauterine growth retardation
Intraventricular haemorrhage
Respiratory distress
Spontaneous abortion*
Fetal death†
Neonatal death‡

8 (16)
4 (8)
4 (8)
0 (0)
15 (30)
7 (14)
2 (4)
1 (2)
0 (0)
0 (0)
3 (6)
1 (2)
1 (2)

*Spontaneous abortion refers to miscarriage before 20 weeks gestation.
†One pregnancy ended with fetal death due to twin–twin transfusion syndrome.
‡Neonatal death occurred 40 days postpartum in an infant born with Trisomy 18.

death in utero due to twin–twin transfusion syndrome. There
was also one fetal death 40 days postpartum in an infant born
with trisomy 18. Preterm delivery (<37 weeks) occurred in 7 of
50 (14%) pregnancies. Low birth weight (<2500 g) was documented in two pregnancies and intrauterine growth retardation
in one. Adverse fetal/neonatal events occurred in 10 of the 20
women with coronary atherosclerosis (50%) and in four of the
18 with a history of coronary thrombosis/embolism (17%).

DISCUSSION
In developed nations, heart disease is the leading indirect cause
of maternal death in pregnancy.1 4 One speciﬁc cardiac condition seen with increasing prevalence in women of childbearing
age is coronary disease. Despite an increasing number of young
women with this condition, the risk of pregnancy in this group
of women has not been well deﬁned. In this study, we found
that women with pre-established CAD or an ACS/MI prior to
pregnancy were at risk for serious adverse maternal cardiac
events (10% of pregnancies) during pregnancy. The highest rates
of non-fatal ischaemic cardiac complications during pregnancy
were experienced by women with atherosclerotic coronary
disease.
Case reports and case series of pregnancy risk in women with
MI prior to pregnancy report maternal mortality ranging
between 0% and 23%.7–9 The largest and most contemporary
report describes 20 women included in the European Registry
on Pregnancy and Heart Disease with an MI prior to pregnancy,
in whom only one experienced new ACS in pregnancy and no
mortality was observed.9 We observed one maternal death in a
woman with a history of MI and moderate LV dysfunction, who
died suddenly at home 2 weeks postpartum. In this case, it is
difﬁcult to differentiate whether this event occurred secondary
to the haemodynamic stress of pregnancy or was simply a manifestation of the natural history of LV dysfunction. Compared
with earlier studies,7 8 maternal mortality was signiﬁcantly
lower in this study. A number of factors may explain this. All
were followed in tertiary cardiac care programmes in the contemporary era, the underlying aetiology of CAD/ACS/MI was
identiﬁed and treated in most, many had undergone coronary
528

Limitations
The study has many limitations inherent to a retrospective
observational study including small cohort size and the absence
of a prospectively matched control group with which outcomes
could be compared. Women included in this study were treated
in maternity programmes linked to tertiary cardiac care centres,
increasing the potential for referral bias. Women with less severe
heart disease may not have been referred for specialist care.
Women with more severe heart disease may have been advised
against pregnancy. To attempt to minimise the impact of referral
and/or institutional bias in care and patient outcomes, this study
included women from two countries, Canada and the
Netherlands. Despite this, outcomes may not reﬂect those
achieved in less specialised centres and in lower-resource
settings.9
In our study, age was not a major determinant of adverse
events. This differs from other studies of MI in pregnancy
Burchill LJ, et al. Heart 2015;101:525–529. doi:10.1136/heartjnl-2014-306676
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Pregnancies
n (%)

revascularisation and almost all women had preserved ventricular function.
Existing tools for assessing global maternal cardiac risk in
pregnancy are the CARPREG and ZAHARA risk scores.12 13
These risk scores incorporate a range of clinical predictors
including previous cardiac events (arrhythmia, heart failure),
poor NYHA functional class, cyanosis, left heart obstruction
and the presence of a mechanical valve. These risk scores,
derived from cohorts of women with structural and congenital
heart disease, were not developed to predict adverse outcomes
in women with pre-established CAD or a history of ACS/MI.
We found that a pre-existing diagnosis of coronary atherosclerosis was helpful in identifying those at highest risk of cardiac
ischaemic events in pregnancy. It is likely that other variables,
such as ischaemia prior to pregnancy, multivessel disease or
smoking, may better predict outcomes. Disease-speciﬁc complications remain important when stratifying risk, as illustrated by
the patient in this study with Ehlers–Danlos syndrome whose
pregnancy was complicated by vascular dissection. Sudden
cardiac death in one woman with ischaemic cardiomyopathy is a
reminder of the potential maternal morbidity and mortality
associated with signiﬁcant ventricular dysfunction.9 14
Obstetric, fetal and neonatal adverse events were common.
Pre-eclampsia and low birth weight appeared to be more
common in women with vascular disease (atherosclerosis and/or
diabetes). This relationship may be a manifestation of the
increased incidence of placental disease in women with systemic
vascular disease and endothelial dysfunction.15 16 We have previously compared the frequency of adverse neonatal outcomes
in pregnant women with and without heart disease,12 who were
prospectively matched at the time of study enrolment. Neonatal
adverse events were much more frequent in women with heart
disease versus controls (18% vs 7%, respectively). In the present
study, we observed a higher rate of adverse neonatal events
(30%), which was primarily driven by early preterm labour and
low birth weight/intrauterine growth restriction. Important differences exist in relation to this and our earlier study cohort,
most notably a low prevalence of CAD (0.02%) and a predominance of women with congenital and valvular heart disease in
the previous study. While the rate of neonatal complications in
the current study is almost twice as high as that observed among
women with congenital/valvular heart disease, it is premature to
conclude that women with CAD or ACS/MI have worse neonatal outcomes. However, the increased rate of neonatal complications in this contemporary cohort of women with CAD or
ACS/MI is concerning and deserves further research.

Special populations
ﬁes women at highest risk of cardiac ischaemic events during
subsequent pregnancy. This information will be helpful for the
clinician; aiding in preconception counselling and risk
stratiﬁcation.
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which have reported that the risk of MI rises incrementally with
maternal age,17 so that by the age of 40 years, women have a
30-fold higher risk of cardiac ischaemia during pregnancy compared with women aged younger than 20 years.5 It is possible
that we failed to detect this association because of our relatively
small cohort size.
In this study, the interval between previous MI and the onset
of pregnancy was often not available, although this is an important determinant of outcome.6 The risk of MI has also been
reported to differ by race or ethnicity, black women reported to
have the highest risk.5 Racial differences in maternal cardiac risk
were not a focus of this study, but may be important. An incidental observation was that women enrolled from The
Netherlands had a high rate of factor V Leiden deﬁciency associated with intracoronary thrombus. To identify predictors of
outcomes in this patient population, prospective studies in
larger sample sizes are needed.

